Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 465841 - 465860 out of 489036 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 0.5MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 0.5MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 0.75MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 0.75MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 1MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | ZORTRESS 1MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 10MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 10MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 10MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 10MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MylanPharmaceuticals,Inc. |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR DISPERZ 2MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR DISPERZ 2MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 2MG TAB,SUSP,ORAL,UD | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MylanPharmaceuticals,Inc. |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 2.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 2.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 2.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MylanPharmaceuticals,Inc. |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 2.5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NationwidePharmaceuticalLLC |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR DISPERZ 3MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS 3MG TAB,SUSP,ORAL,UD | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MylanPharmaceuticals,Inc. |
USA | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 5MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |